M-161

N/A

Report date: 2025/03/18 13:50:32

Base Information

Drug NameM-161
Drug Alias NameM-161
ClassificationBiologics > Protein drugs > Enzyme
Mechanisms of ActionN-acetylgalactosamine-6-sulfatase replacements
TargetsN-acetylgalactosamine-6-sulfatase
Therapy Area/IndicationsMucopolysaccharidosis IV
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesM6P Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesM6P Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis IV
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A